Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium
-
Published:2023-05
Issue:5
Volume:28
Page:2008-2017
-
ISSN:1359-4184
-
Container-title:Molecular Psychiatry
-
language:en
-
Short-container-title:Mol Psychiatry
Author:
Dwyer Dominic B.ORCID, Chand Ganesh B., Pigoni AlessandroORCID, Khuntia Adyasha, Wen JunhaoORCID, Antoniades Mathilde, Hwang GyujoonORCID, Erus GurayORCID, Doshi Jimit, Srinivasan Dhivya, Varol Erdem, Kahn Rene S.ORCID, Schnack Hugo G., Meisenzahl Eva, Wood Stephen J., Zhuo ChuanjunORCID, Sotiras AristeidisORCID, Shinohara Russell T., Shou Haochang, Fan Yong, Schaulfelberger Maristela, Rosa Pedro, Lalousis Paris A.ORCID, Upthegrove Rachel, Kaczkurkin Antonia N.ORCID, Moore Tyler M.ORCID, Nelson Barnaby, Gur Raquel E., Gur Ruben C., Ritchie Marylyn D.ORCID, Satterthwaite Theodore D., Murray Robin M.ORCID, Di Forti Marta, Ciufolini Simone, Zanetti Marcus V., Wolf Daniel H.ORCID, Pantelis ChristosORCID, Crespo-Facorro Benedicto, Busatto Geraldo F., Davatzikos ChristosORCID, Koutsouleris NikolaosORCID, Dazzan PaolaORCID
Abstract
AbstractUsing machine learning, we recently decomposed the neuroanatomical heterogeneity of established schizophrenia to discover two volumetric subgroups—a ‘lower brain volume’ subgroup (SG1) and an ‘higher striatal volume’ subgroup (SG2) with otherwise normal brain structure. In this study, we investigated whether the MRI signatures of these subgroups were also already present at the time of the first-episode of psychosis (FEP) and whether they were related to clinical presentation and clinical remission over 1-, 3-, and 5-years. We included 572 FEP and 424 healthy controls (HC) from 4 sites (Sao Paulo, Santander, London, Melbourne) of the PHENOM consortium. Our prior MRI subgrouping models (671 participants; USA, Germany, and China) were applied to both FEP and HC. Participants were assigned into 1 of 4 categories: subgroup 1 (SG1), subgroup 2 (SG2), no subgroup membership (‘None’), and mixed SG1 + SG2 subgroups (‘Mixed’). Voxel-wise analyses characterized SG1 and SG2 subgroups. Supervised machine learning analyses characterized baseline and remission signatures related to SG1 and SG2 membership. The two dominant patterns of ‘lower brain volume’ in SG1 and ‘higher striatal volume’ (with otherwise normal neuromorphology) in SG2 were identified already at the first episode of psychosis. SG1 had a significantly higher proportion of FEP (32%) vs. HC (19%) than SG2 (FEP, 21%; HC, 23%). Clinical multivariate signatures separated the SG1 and SG2 subgroups (balanced accuracy = 64%; p < 0.0001), with SG2 showing higher education but also greater positive psychosis symptoms at first presentation, and an association with symptom remission at 1-year, 5-year, and when timepoints were combined. Neuromorphological subtypes of schizophrenia are already evident at illness onset, separated by distinct clinical presentations, and differentially associated with subsequent remission. These results suggest that the subgroups may be underlying risk phenotypes that could be targeted in future treatment trials and are critical to consider when interpreting neuroimaging literature.
Funder
U.S. Department of Health & Human Services | National Institutes of Health U.S. Department of Health & Human Services | NIH | National Institute of Mental Health Department of Health | National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference50 articles.
1. Haijma SV, Van Haren N, Cahn W, Koolschijn PCM, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129–38. 2. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281–8. 3. Koutsouleris N, Gaser C, Jager M, Bottlender R, Frodl T, Holzinger S, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study. Neuroimage. 2008;39:1600–12. 4. Abi-Dargham A, Horga G. The search for imaging biomarkers in psychiatric disorders. Nat Med. 2016;22:1248–55. 5. Insel TR, Cuthbert BN. Brain disorders? Precisely. Science. 2015;348:499–500.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|